Podcast
Latest Episodes
FDA decisions, clinical trial results, biotech M&A, and drug pipeline updates in under 15 minutes.
Latest Episode · Mar 13
GSK Arexvy RSV Vaccine Expansion & Novartis Cosentyx Pediatric Approval
GSK's Arexvy RSV vaccine wins expansion to ages 18-49 and Novartis gets pediatric approval for Cosentyx — what these moves signal for the competitive landscape.
Mar 12
Ultragenyx Gene Therapy Phase 3 & Lilly's $3B China Investment
Gene therapy milestones, Eli Lilly doubles down on China, and a LAG-3 setback shakes immunology.
10 min
▶
Mar 11
Vertex Kidney Drug Phase 3 & UCB Bimzelx vs Skyrizi Data
Vertex moves into renal, and head-to-head data reshuffles the IL-17 competitive landscape.
6 min
▶
Mar 10
BioNTech Co-Founders Departure & FDA Approval Without Clinical Trial
Leadership shakeup at BioNTech and an unprecedented FDA approval path — what it means.
7 min
▶